• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以一种新型血小板反应性评分表示的血小板反应性与冠状动脉搭桥术后较高的炎症状态相关。

Platelet reactivity expressed as a novel platelet reactivity score is associated with higher inflammatory state after coronary artery bypass grafting.

作者信息

Wilczyński Mirosław, Krejca Michał, Stepinski Piotr, Rozalski Marcin, Golanski Jacek

机构信息

Department of Cardiac Surgery, Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Lodz, Poland.

Department of Haemostasis and Haemostatic Disorders, Medical University of Lodz, Lodz, Poland.

出版信息

Arch Med Sci. 2019 Dec 12;19(2):392-400. doi: 10.5114/aoms.2019.90470. eCollection 2023.

DOI:10.5114/aoms.2019.90470
PMID:37034540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10074322/
Abstract

INTRODUCTION

Despite therapy, patients operated using a cardiopulmonary bypass demonstrate increased platelet aggregation, which rebounds to above preoperative levels. The aim of the study was to test the interaction between platelet reactivity/activation and selected inflammatory markers in the post-operative period.

MATERIAL AND METHODS

In total, 103 patients with non-ST elevation acute coronary syndrome (NSTE-ACS) who were not eligible for percutaneous coronary interventions (PCI), and required urgent revascularization, were included. Platelet reactivity was measured using the PFA-100 platelet analyser, multiple electrode aggregometry, and was expressed as a novel platelet reactivity score (PRS). Patients were divided using their PRS scores into high platelet relativity or low platelet reactivity subgroups (HPR or LPR). Platelet basal activation was measured using immunoassays for soluble P-selectin and soluble CD40L. We measured high-sensitivity C-reactive protein (CRP), and used immunoassays for tumour necrosis factor α (TNF-α) and interleukin 6 (IL-6) as inflammation markers.

RESULTS

Significant differences between HPR and LPR groups were found for CRP (mg/l): 81.5 vs. 44.6, < 0.02; and TNF-α (pg/l): 3.51 vs. 2.37, < 0.02. A significant association was found between CRP, TNF-α, IL-6 and platelet reactivity (platelet reactivity score). Cohen's k showed: CRP = 0.49, < 0.0001, TNF-α = 0.37, < 0.002. Perioperative myocardial infarction and rhythm disturbances occurred more frequently in the high platelet reactivity group: 7 (16.3%) vs. 2 (3.3%), < 0.04, and 9 (20.9%) vs. 4 (6.7%), < 0.04, respectively.

CONCLUSIONS

Inflammatory parameters CRP and TNF-α are strongly associated with platelet reactivity (expressed as PRS) in cardiopulmonary bypass graft patients. Platelet hyperreactivity in the early post-operative period combined with a systemic inflammatory state correlates with a higher risk of post-operative rhythm disturbances and myocardial infarction.

摘要

引言

尽管进行了治疗,但接受体外循环手术的患者血小板聚集增加,且会反弹至术前水平以上。本研究的目的是测试术后血小板反应性/活化与选定炎症标志物之间的相互作用。

材料与方法

总共纳入了103例不符合经皮冠状动脉介入治疗(PCI)条件且需要紧急血运重建的非ST段抬高型急性冠状动脉综合征(NSTE-ACS)患者。使用PFA-100血小板分析仪、多电极聚集测定法测量血小板反应性,并表示为一种新的血小板反应性评分(PRS)。根据PRS评分将患者分为高血小板反应性或低血小板反应性亚组(HPR或LPR)。使用可溶性P-选择素和可溶性CD40L的免疫测定法测量血小板基础活化。我们测量了高敏C反应蛋白(CRP),并使用肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6)的免疫测定法作为炎症标志物。

结果

HPR组和LPR组在CRP(mg/l)方面存在显著差异:81.5对44.6,P<0.02;TNF-α(pg/l)方面:3.51对2.37,P<0.02。发现CRP、TNF-α、IL-6与血小板反应性(血小板反应性评分)之间存在显著关联。科恩kappa系数显示:CRP=0.49,P<0.0001,TNF-α=0.37,P<0.002。高血小板反应性组围手术期心肌梗死和心律失常的发生率更高:分别为7例(16.3%)对2例(3.3%),P<0.04,以及9例(20.9%)对4例(6.7%),P<0.04。

结论

炎症参数CRP和TNF-α与体外循环搭桥患者的血小板反应性(以PRS表示)密切相关。术后早期血小板高反应性与全身炎症状态相结合,与术后心律失常和心肌梗死的较高风险相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/10074322/30853ca4b2fa/AMS-19-2-111842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/10074322/9c854fb104ca/AMS-19-2-111842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/10074322/30853ca4b2fa/AMS-19-2-111842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/10074322/9c854fb104ca/AMS-19-2-111842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/10074322/30853ca4b2fa/AMS-19-2-111842-g002.jpg

相似文献

1
Platelet reactivity expressed as a novel platelet reactivity score is associated with higher inflammatory state after coronary artery bypass grafting.以一种新型血小板反应性评分表示的血小板反应性与冠状动脉搭桥术后较高的炎症状态相关。
Arch Med Sci. 2019 Dec 12;19(2):392-400. doi: 10.5114/aoms.2019.90470. eCollection 2023.
2
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).经皮冠状动脉介入治疗患者血小板反应性和 C 反应蛋白水平与围手术期心肌梗死发生的相关性(来自 ARMYDA-CRP 研究)。
Am J Cardiol. 2013 Jun 15;111(12):1739-44. doi: 10.1016/j.amjcard.2013.02.028. Epub 2013 Mar 26.
3
The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes.炎症和血小板生物标志物在急性冠状动脉综合征患者中的应用
Saudi J Biol Sci. 2018 Nov;25(7):1263-1271. doi: 10.1016/j.sjbs.2016.10.015. Epub 2016 Oct 24.
4
Association of platelet-monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non-st elevation acute coronary syndromes.非ST段抬高型急性冠状动脉综合征患者中血小板-单核细胞聚集体与血小板活化、全身炎症及心肌损伤的关联
Clin Cardiol. 2007 Jan;30(1):26-31. doi: 10.1002/clc.2.
5
High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.氯吡格雷治疗时血小板高反应性在急性支架置入术中很常见,而在择期支架置入术中很少见,可以通过治疗转换来功能性克服。
Thromb Res. 2014 Feb;133(2):257-64. doi: 10.1016/j.thromres.2013.11.029. Epub 2013 Dec 6.
6
High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study.治疗中血小板高反应性与老年非 ST 段抬高型急性冠状动脉综合征患者的结局——来自 GEPRESS 研究的观察。
Int J Cardiol. 2018 May 15;259:20-25. doi: 10.1016/j.ijcard.2018.01.057.
7
Effect of Clopidogrel vs Ticagrelor on Platelet Aggregation and Inflammation Markers After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.氯吡格雷与替格瑞洛对 ST 段抬高型心肌梗死经皮冠状动脉介入治疗后血小板聚集和炎症标志物的影响。
Can J Cardiol. 2018 Dec;34(12):1606-1612. doi: 10.1016/j.cjca.2018.08.024. Epub 2018 Aug 20.
8
Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome.急性冠脉综合征患者血小板反应性与循环血小板衍生微泡之间的关联
Platelets. 2015;26(5):467-73. doi: 10.3109/09537104.2014.940304. Epub 2014 Jul 15.
9
Relationship Between Platelet Reactivity and Periprocedural Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗患者血小板反应性与围手术期心肌坏死的关系
J Invasive Cardiol. 2019 Dec;31(12):E369-E375.
10
Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.残余血小板反应性对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者再灌注的影响。
Eur Heart J Acute Cardiovasc Care. 2016 Sep;5(5):475-86. doi: 10.1177/2048872615624849. Epub 2016 Jan 12.

引用本文的文献

1
The relationship between ABO blood types and clopidogrel-related low on-treatment platelet reactivity in patients with coronary artery diseases and type 2 diabetes mellitus: a secondary analysis of a prospective cohort study.冠心病合并2型糖尿病患者ABO血型与氯吡格雷相关的治疗中血小板低反应性的关系:一项前瞻性队列研究的二次分析
Diabetol Metab Syndr. 2025 May 13;17(1):151. doi: 10.1186/s13098-025-01716-6.
2
The Value of Biomarkers in Major Cardiovascular Surgery Necessitating Cardiopulmonary Bypass.生物标志物在需要体外循环的重大心血管手术中的价值
Rev Cardiovasc Med. 2024 Sep 30;25(10):355. doi: 10.31083/j.rcm2510355. eCollection 2024 Oct.
3

本文引用的文献

1
Long-term outcomes of percutaneous coronary interventions within coronary artery bypass grafts.冠状动脉旁路移植术中经皮冠状动脉介入治疗的长期疗效
Arch Med Sci. 2019 Jan 30;17(3):628-637. doi: 10.5114/aoms.2018.75608. eCollection 2021.
2
The effect of the *2 allele on cardiovascular outcomes in patients with coronary artery stenting: a prospective study.*2等位基因对冠状动脉支架置入患者心血管结局的影响:一项前瞻性研究。
Arch Med Sci. 2019 Jul;15(4):837-844. doi: 10.5114/aoms.2018.75349. Epub 2018 Apr 23.
3
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.
Platelet transfusion enhances pro-aggregatory status shortly after coronary artery bypass grafting (CABG while modulating platelet pro-inflammatory state 1-week post-surgery.
血小板输注在冠状动脉旁路移植术(CABG)后不久增强促聚集状态,同时在手术后 1 周调节血小板促炎状态。
J Cell Mol Med. 2024 Aug;28(15):e18573. doi: 10.1111/jcmm.18573.
4
An Evaluation of Plasma TNF, VEGF-A, and IL-6 Determination as a Risk Marker of Atherosclerotic Vascular Damage in Early-Onset CAD Patients.血浆肿瘤坏死因子、血管内皮生长因子-A和白细胞介素-6测定作为早发冠心病患者动脉粥样硬化血管损伤风险标志物的评估
J Clin Med. 2024 Mar 18;13(6):1742. doi: 10.3390/jcm13061742.
5
Cardiopulmonary bypass associated acute kidney injury: better understanding and better prevention.体外循环相关急性肾损伤:更好的理解和更好的预防。
Ren Fail. 2024 Dec;46(1):2331062. doi: 10.1080/0886022X.2024.2331062. Epub 2024 Mar 21.
6
Platelet Reactivity in the Exacerbation of Psoriasis.银屑病加重期的血小板反应性
J Clin Med. 2024 Feb 8;13(4):965. doi: 10.3390/jcm13040965.
7
Could Tumor Necrosis Factor Serve as a Marker for Cardiovascular Risk Factors and Left Ventricular Hypertrophy in Patients with Early-Onset Coronary Artery Disease?肿瘤坏死因子能否作为早发冠状动脉疾病患者心血管危险因素和左心室肥厚的标志物?
Diagnostics (Basel). 2024 Feb 18;14(4):449. doi: 10.3390/diagnostics14040449.
8
[Procalcitonin as sepsis predictor in cardiovascular surgery with cardiopulmonary bypass].[降钙素原在体外循环心血管手术中作为脓毒症预测指标的研究]
Rev Med Inst Mex Seguro Soc. 2023 Nov 6;61(6):802-808. doi: 10.5281/zenodo.10064366.
更新的血小板功能和基因检测指导经皮冠状动脉介入治疗中 P2Y 受体抑制剂治疗的专家共识声明。
JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537. doi: 10.1016/j.jcin.2019.03.034. Epub 2019 Jun 12.
4
Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy.接受双联抗血小板治疗的血脂异常冠心病患者血小板反应性增加。
Arch Med Sci. 2019 Jan;15(1):65-71. doi: 10.5114/aoms.2018.81035. Epub 2018 Dec 30.
5
Network meta-analysis of antiplatelet therapy following coronary artery bypass grafting (CABG): none versus one versus two antiplatelet agents.冠状动脉旁路移植术(CABG)后抗血小板治疗的网络荟萃分析:无抗血小板药物与一种抗血小板药物与两种抗血小板药物的比较
Ann Cardiothorac Surg. 2018 Sep;7(5):577-585. doi: 10.21037/acs.2018.09.02.
6
Increased platelet reactivity and platelet-leukocyte aggregation after elective coronary bypass surgery.择期冠状动脉旁路手术后血小板反应性和血小板-白细胞聚集体增加。
Platelets. 2019;30(8):975-981. doi: 10.1080/09537104.2018.1542122. Epub 2018 Nov 13.
7
Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery.定量检测未成熟血小板作为冠状动脉旁路移植术后血小板生成增加的标志物。
Eur J Haematol. 2018 Sep;101(3):362-367. doi: 10.1111/ejh.13109. Epub 2018 Jul 27.
8
Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery.冠状动脉旁路移植术后围手术期心肌梗死的双联抗血小板治疗。
Am Heart J. 2018 May;199:150-155. doi: 10.1016/j.ahj.2018.02.006. Epub 2018 Feb 11.
9
Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromes.全身炎症状态与急性冠脉综合征后早期血小板反应性增加有关。
Platelets. 2018 Jul;29(5):528-530. doi: 10.1080/09537104.2018.1457782. Epub 2018 Apr 4.
10
C-Reactive Protein in Atherothrombosis and Angiogenesis.C 反应蛋白在动脉粥样血栓形成和血管生成中的作用。
Front Immunol. 2018 Mar 2;9:430. doi: 10.3389/fimmu.2018.00430. eCollection 2018.